Skip to main content

Articles

1529 result(s) for 'neurology impact factor' within BMC Neurology

Page 29 of 31

  1. Multiple sclerosis (MS) is an incurable, unpredictable but typically progressive neurological condition. It is the most common cause of neurological disability in young adults. Within 15 years of diagnosis, ap...

    Authors: J. A. Freeman, W. Hendrie, S. Creanor, L. Jarrett, A. Barton, C. Green, J. Marsden, E. Rogers and J. Zajicek
    Citation: BMC Neurology 2016 16:62
  2. Phase 3 trials supporting dextromethorphan/quinidine (DM/Q) use as a treatment for pseudobulbar affect (PBA) were conducted in patients with amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The ...

    Authors: Flora M. Hammond, David N. Alexander, Andrew J. Cutler, Stephen D’Amico, Rachelle S. Doody, William Sauve, Richard D. Zorowitz, Charles S. Davis, Paul Shin, Fred Ledon, Charles Yonan, Andrea E. Formella and Joao Siffert
    Citation: BMC Neurology 2016 16:89

    The Erratum to this article has been published in BMC Neurology 2016 16:160

  3. Multiple sclerosis (MS) patients often struggle with treatment decisions, in part due to the increasing number of approved disease modifying therapies, each with different characteristics, and also since physi...

    Authors: Nick Bansback, Judy A. Chiu, Robert Carruthers, Rebecca Metcalfe, Emmanuelle Lapointe, Alice Schabas, Marilyn Lenzen, Larry D. Lynd and Anthony Traboulsee
    Citation: BMC Neurology 2019 19:173
  4. Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging populations, longer disease duration and potentially as a CO...

    Authors: Ann Liebert, Brian Bicknell, E-Liisa Laakso, Gillian Heller, Parastoo Jalilitabaei, Sharon Tilley, John Mitrofanis and Hosen Kiat
    Citation: BMC Neurology 2021 21:256
  5. Minocycline, a member of the tetracycline family, has a low risk of adverse effects and an ability to improve behavioral performance in humans with cognitive disruption. We performed a single-arm open-label tr...

    Authors: Joseph C Grieco, Stephanie L Ciarlone, Maria Gieron-Korthals, Mike R Schoenberg, Amanda G Smith, Rex M Philpot, Helen S Heussler, Jessica L Banko and Edwin J Weeber
    Citation: BMC Neurology 2014 14:232
  6. Parkinson’s disease is complicated by comorbidity and polypharmacy, but the extent and patterns of these are unclear. We describe comorbidity and polypharmacy in patients with and without Parkinson’s disease a...

    Authors: Gary McLean, John V. Hindle, Bruce Guthrie and Stewart W. Mercer
    Citation: BMC Neurology 2017 17:126
  7. The treatment of cognitive deficits is challenging in pediatric onset multiple sclerosis (POMS) and in patients with attention deficit hyperactivity disorder (ADHD). We performed a pilot double-blind RCT to ev...

    Authors: Marta Simone, Rosa Gemma Viterbo, Lucia Margari and Pietro Iaffaldano
    Citation: BMC Neurology 2018 18:82
  8. Constipation is one of the most frequent non-motor symptoms (NMS) in Parkinson’s disease (PD) and the prevalence of constipation in PD patients varies among different studies. We designed this study to survey ...

    Authors: Jing Gan, Ying Wan, Junjie Shi, Mingzhu Zhou, Zhiyin Lou and Zhenguo Liu
    Citation: BMC Neurology 2018 18:29
  9. Adult neurogenesis persists through life at least in classic neurogenic niches. Neurogenesis has been previously described as reduced in neurodegenerative diseases. There is not much knowledge about is adult n...

    Authors: Lucía Galán, Ulises Gómez-Pinedo, Antonio Guerrero, Jose Manuel García-Verdugo and Jorge Matías-Guiu
    Citation: BMC Neurology 2017 17:173
  10. Multiple sclerosis (MS) patients often suffer from gait impairment and fampridine is indicated to medically improve walking ability in this population. Patient characteristics, healthcare resource use, and cos...

    Authors: Tjalf Ziemssen, Christine Prosser, Jennifer Scarlet Haas, Andrew Lee, Sebastian Braun, Pamela Landsman-Blumberg, Angela Kempel, Erika Gleißner, Sarita Patel and Ming-Yi Huang
    Citation: BMC Neurology 2017 17:62
  11. Among the 21 annotated genes at Xq22.2, PLP1 is the only known gene involved in Xq22.2 microdeletion and microduplication syndromes with intellectual disability. Using an atypical microdeletion, which does not en...

    Authors: Jonathan D. J. Labonne, Tyler D. Graves, Yiping Shen, Julie R. Jones, Il-Keun Kong, Lawrence C. Layman and Hyung-Goo Kim
    Citation: BMC Neurology 2016 16:132
  12. The effectiveness of mobile technology to improve medication adherence via customized Short Messaging Service (SMS) reminders for stroke has not been tested in resource poor areas. We designed a randomized con...

    Authors: Ayeesha Kamran Kamal, Quratulain Shaikh, Omrana Pasha, Iqbal Azam, Muhammad Islam, Adeel Ali Memon, Hasan Rehman, Masood Ahmed Akram, Muhammad Affan, Sumaira Nazir, Salman Aziz, Muhammad Jan, Anita Andani, Abdul Muqeet, Bilal Ahmed and Shariq Khoja
    Citation: BMC Neurology 2015 15:212
  13. The NINDS-Canadian Stroke Network (NINDS-CSN) recommended a neuropsychological battery of three protocols to diagnose vascular cognitive impairment (VCI), however, due to culture and language differences, the ...

    Authors: Xiangliang Chen, Adrian Wong, Ruidong Ye, Lulu Xiao, Zhaojun Wang, Ying Lin, Fang Yang, Hua Li, Ting Feng, Lihui Duan, Yunfei Han, Qiliang Dai, Juan Du, Gelin Xu, Vincent Mok, Yunyun Xiong…
    Citation: BMC Neurology 2015 15:20
  14. Stroke is a serious cardiovascular disease and is also the leading cause of long-term disability in developing and developed countries. Because matrix metalloproteinase-9 (MMP-9) is associated with the risk of ma...

    Authors: Ning Gao, Tie Guo, Han Luo, Guolong Tu, Fanglin Niu, Mengdan Yan and Ying Xia
    Citation: BMC Neurology 2019 19:67
  15. Complications after stroke have been associated with poor outcome. Modern stroke treatment might reduce the occurrence of complications. The aim of this study was to investigate whether the frequency and type ...

    Authors: Martina Reiten Bovim, Torunn Askim, Stian Lydersen, Hild Fjærtoft and Bent Indredavik
    Citation: BMC Neurology 2016 16:133
  16. To evaluate the relationship between the flow signal intensity of branch arteries distal to the stenosis on 3-dimensional (3D) time-of-flight (TOF) magnetic resonance angiography (MRA) and the risk of stroke r...

    Authors: Hongbing Chen, Zhuhao Li, Hua Hong, Shihui Xing, Gang Liu, Aiwu Zhang, Shuangquan Tan, Jian Zhang and Jinsheng Zeng
    Citation: BMC Neurology 2015 15:167
  17. Endovascular treatment (EVT) is advocated for acute ischaemic stroke with large-vessel occlusion (LVO), but perioperative periods are challenging. This study investigated the relationship between post-EVT shor...

    Authors: Tianli Zhang, Xiaolong Wang, Chao Wen, Feng Zhou, Shengwei Gao, Xiaodong Zhang, Shiqin Lin, Jing Shi and Weirong Li
    Citation: BMC Neurology 2019 19:228
  18. Myotonic Dystrophy 1 (DM1) causes progressive myopathy of extremity muscles. DM1 may also affect muscles of the trunk. The aim of this study was to investigate fat infiltration and muscle size in trunk muscles...

    Authors: Gro Solbakken, Bård Bjørnarå, Eva Kirkhus, Bac Nguyen, Gunnar Hansen, Jan C. Frich and Kristin Ørstavik
    Citation: BMC Neurology 2019 19:135
  19. Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus with significant clinical sequelae that can affect a patient’s quality of life. Metabolic and microvascular factors are...

    Authors: Gesa Meyer-Hamme, Thomas Friedemann, Henry Johannes Greten, Rosemarie Plaetke, Christian Gerloff and Sven Schroeder
    Citation: BMC Neurology 2018 18:40
  20. In this study, we aimed to understand the trends in total and itemized medical expenses, especially of disease-modifying therapy (DMT), for multiple sclerosis (MS) in Japan through an analysis of health insura...

    Authors: Izumi Kawachi, Shuichi Okamoto, Mariko Sakamoto, Hiroyuki Ohta, Yusuke Nakamura, Kosuke Iwasaki, Manami Yoshida, Shinzo Hiroi and Mieko Ogino
    Citation: BMC Neurology 2019 19:324
  21. Cholinesterase inhibitors are used to treat the symptoms of dementia and can theoretically cause bradycardia. Previous studies suggest that patients taking these medications have an increased risk of undergoin...

    Authors: Allen R Huang, Calum J Redpath and Carl van Walraven
    Citation: BMC Neurology 2015 15:66
  22. Previous studies examining social work interventions in stroke often lack information on content, methods and timing over different phases of care including acute hospital, rehabilitation and out-patient care....

    Authors: Inken Padberg, Petra Knispel, Susanne Zöllner, Meike Sieveking, Alice Schneider, Jens Steinbrink, Peter U. Heuschmann, Ian Wellwood and Andreas Meisel
    Citation: BMC Neurology 2016 16:111
  23. Evidence on the use of fingolimod in real-world clinical practice and data on patient-reported health-related quality of life (HRQoL) in countries such as the Middle East are sparse. The Prospective Evaluation...

    Authors: Anat Achiron, Hany Aref, Jihad Inshasi, Mohamad Harb, Raed Alroughani, Mahendra Bijarnia, Kathryn Cooke and Ozgur Yuksel
    Citation: BMC Neurology 2017 17:150
  24. Glatiramer acetate is worldwide used as first line treatment in relapsing remitting multiple sclerosis. Local skin reactions associated with glatiramer acetate are common, however, only isolated cases of sever...

    Authors: Chiara Zecca, Carlo Mainetti, Roland Blum and Claudio Gobbi
    Citation: BMC Neurology 2015 15:249
  25. Pompe disease is a rare autosomal recessive disorder caused by a deficiency of the lysosomal enzyme alpha-glucosidase responsible for degrading glycogen. Late-onset Pompe disease has a complex multisystem phen...

    Authors: Fatma Al Jasmi, Mohammed Al Jumah, Fatimah Alqarni, Nouriya Al-Sanna’a, Fawziah Al-Sharif, Saeed Bohlega, Edward J. Cupler, Waseem Fathalla, Mohamed A. Hamdan, Nawal Makhseed, Shahriar Nafissi, Yalda Nilipour, Laila Selim, Nuri Shembesh, Rawda Sunbul and Seyed Hassan Tonekaboni
    Citation: BMC Neurology 2015 15:205
  26. Multiple sclerosis (MS) and epilepsy are both fairly common and it follows that they may sometimes occur together in the same people by chance. We sought to determine whether hospitalisation for MS and hospita...

    Authors: Alexander N Allen, Olena O Seminog and Michael J Goldacre
    Citation: BMC Neurology 2013 13:189
  27. The SPAN-100 index adds patient age and baseline NIHSS-score and was introduced to predict clinical outcome after acute ischemic stroke (AIS). Even with high NIHSS-scores younger patients cannot reach a SPAN-1...

    Authors: Cornelia Möbius, Christian Blinzler, Stefan Schwab, Martin Köhrmann and Lorenz Breuer
    Citation: BMC Neurology 2018 18:129
  28. Few previous hemodynamic studies demonstrated the detailed features of rupture point of intracranial aneurysms. The hemodynamic simulation for the case that ruptured during angiography was even rare. In the pr...

    Authors: Yisen Zhang, Linkai Jing, Ying Zhang, Jian Liu and Xinjian Yang
    Citation: BMC Neurology 2016 16:231
  29. Ultrasound accelerates thrombolysis with tPA (sonothrombolysis). Ultrasound in the absence of tPA also accelerates clot break-up (sonolysis). Adding intravenous gaseous microbubbles may potentiate the effect o...

    Authors: Aliona Nacu, Christopher E. Kvistad, Nicola Logallo, Halvor Naess, Ulrike Waje-Andreassen, Anne Hege Aamodt, Ragnar Solhoff, Christian Lund, Håkon Tobro, Ole Morten Rønning, Rolf Salvesen, Titto T. Idicula and Lars Thomassen
    Citation: BMC Neurology 2015 15:110
  30. In order to evaluate the impact of cilostazol on endothelial function, we compared the changes of flow-mediated dilation (FMD) between aspirin and cilostazol groups in patients with acute cerebral ischemia.

    Authors: Seong-Joon Lee, Jin Soo Lee, Mun Hee Choi, Sung Eun Lee, Dong Hoon Shin and Ji Man Hong
    Citation: BMC Neurology 2017 17:169
  31. Delayed recovery in persons after mild traumatic brain injury (mTBI) is poorly understood. Community integration (CI) is endorsed by persons with neurological disorders as an important outcome. We aimed to des...

    Authors: Tatyana Mollayeva, Colin M. Shapiro, Shirin Mollayeva, J. David Cassidy and Angela Colantonio
    Citation: BMC Neurology 2015 15:194
  32. Intravenous thrombolysis has been recently introduced in Nepal for the management of acute ischemic stroke. Pre-hospital delay is one of the main reasons that hinder thrombolytic therapy. The objective of this...

    Authors: Gaurav Nepal, Jayant Kumar Yadav, Babin Basnet, Tirtha Man Shrestha, Ghanshyam Kharel and Rajeev Ojha
    Citation: BMC Neurology 2019 19:155
  33. Patients frequently fail to receive adequate pain relief from, or are intolerant of, first-line therapies prescribed for neuropathic pain (NeP). This refractory chronic pain causes psychological distress and i...

    Authors: Melanie Plested, Sangeeta Budhia and Zahava Gabriel
    Citation: BMC Neurology 2010 10:116
  34. Intravenous thrombolysis therapy (IVT) bridged with intra-arterial thrombectomy (IAT) has recently been recommended as favorable treatment option to ensure that the thrombolytic effect is delivered to the affe...

    Authors: Yu-Jun Chang, Chi-Kuang Liu, Wen-Pei Wu, Shih-Chun Wang, Wei-Liang Chen and Chih-Ming Lin
    Citation: BMC Neurology 2020 20:22
  35. Pro-inflammatory processes underlie ischemic stroke, albeit it is largely unknown if they selectively associate with the risk of atherothrombotic or cardioembolic ischemic stroke. Here we analyze whether pro-i...

    Authors: Louise Ziegler, Håkan Wallén, Sara Aspberg, Ulf de Faire and Bruna Gigante
    Citation: BMC Neurology 2021 21:306

    The Correction to this article has been published in BMC Neurology 2022 22:337

  36. The Multiple Sclerosis Questionnaire for Physical Therapists (MSQPT) is a patient-rated outcome questionnaire for evaluating the rehabilitation of persons with multiple sclerosis (MS). Responsiveness was evalu...

    Authors: Nico Arie van der Maas
    Citation: BMC Neurology 2017 17:50
  37. Epilepsy is a serious and costly long-term condition that negatively affects quality of life, especially if seizures persist on medication. Studies show that people with epilepsy (PWE) want to learn more about...

    Authors: Amelia Smith, Alison McKinlay, Gabriella Wojewodka and Leone Ridsdale
    Citation: BMC Neurology 2017 17:114
  38. Recently, minimal invasive surgery (MIS) has been applied as a common therapeutic approach for treatment of hypertensive intracerebral hemorrhage (HICH). However, the efficacy and safety of MIS is still contro...

    Authors: Yiping Tang, Fengqiong Yin, Dengli Fu, Xinhai Gao, Zhengchao Lv and Xuetao Li
    Citation: BMC Neurology 2018 18:136
  39. Multiple sclerosis (MS) is a demyelinating disease with a wide range of symptoms including walking impairment and neuropathic pain mainly represented by mechanical allodynia. Noteworthy, exercise preconditioni...

    Authors: Danielle Bernardes and Alexandre Leite Rodrigues Oliveira
    Citation: BMC Neurology 2017 17:160
  40. Acceptance and Commitment Therapy (ACT), as a type of behavioral therapy, attempts to respond to changes in people’s performance and their relationship to events. ACT can affect sleep quality by providing tech...

    Authors: Nader Salari, Habibolah Khazaie, Amin Hosseinian-Far, Behnam Khaledi-Paveh, Hooman Ghasemi, Masoud Mohammadi and Shamarina Shohaimi
    Citation: BMC Neurology 2020 20:300
  41. Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple sclerosis (MS), which is a chronic neurological disease, characterised by inflammation of the central nervous system. Most of MS patient...

    Authors: Vijayalakshmi Vasanthaprasad, Vivek Khurana, Sreelatha Vadapalle, Jackie Palace and Nicholas Adlard
    Citation: BMC Neurology 2022 22:301
  42. Niemann-Pick disease type C (NP-C) is a rare neurovisceral lipid storage disorder characterised by progressive, disabling neurological symptoms and premature death in most patients. During the last decade, nat...

    Authors: Jackie Imrie, Lesley Heptinstall, Stephen Knight and Kate Strong
    Citation: BMC Neurology 2015 15:257
  43. Mixed pathology, particularly Alzheimer’s disease with cerebrovascular lesions, is reported as the second most common cause of dementia. Research on mixed dementia typically includes people with a primary AD d...

    Authors: Elizabeth Dao, Ging-Yuek Robin Hsiung, Vesna Sossi, Claudia Jacova, Roger Tam, Katie Dinelle, John R. Best and Teresa Liu-Ambrose
    Citation: BMC Neurology 2015 15:197
  44. In patients with ischemic stroke of non-cardioembolic origin, acetylsalicylic acid, clopidogrel, or a combination of acetylsalicylic acid and dipyridamole are recommended for the prevention of a recurrent stro...

    Authors: Christine Benn Christiansen, Jannik Pallisgaard, Thomas Alexander Gerds, Jonas Bjerring Olesen, Mads Emil Jørgensen, Anna Karin Numé, Nicholas Carlson, Søren Lund Kristensen, Gunnar Gislason and Christian Torp-Pedersen
    Citation: BMC Neurology 2015 15:225
  45. A visual field defect (VFD) is a common consequence of stroke with a detrimental effect upon the survivors’ functional ability and quality of life. The identification of effective treatments for VFD is a key p...

    Authors: Tobias Loetscher, Celia Chen, Sophie Wignall, Andreas Bulling, Sabrina Hoppe, Owen Churches, Nicole A Thomas, Michael E R Nicholls and Andrew Lee
    Citation: BMC Neurology 2015 15:64
  46. Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder that is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-ana...

    Authors: Hui Wu, Hui Li, Zhiqiang Shi, Jiajia Tang, Shuya Mei, Tianyi Ai and Zhenzhou He
    Citation: BMC Neurology 2020 20:19
  47. The worldwide prevalence of dementia is rapidly rising. Alzheimer’s disease (AD), accounts for 70% of cases and has a 10–20-year preclinical period, when brain pathology covertly progresses before cognitive sy...

    Authors: Jane Alty, Quan Bai, Renjie Li, Katherine Lawler, Rebecca J. St George, Edward Hill, Aidan Bindoff, Saurabh Garg, Xinyi Wang, Guan Huang, Kaining Zhang, Kaylee D. Rudd, Larissa Bartlett, Lynette R. Goldberg, Jessica M. Collins, Mark R. Hinder…
    Citation: BMC Neurology 2022 22:266
  48. Neuromyelitis optica spectrum disorders (NMOSD) is a group of autoimmune-mediated disorders of the central nervous system primarily involving the optic nerve and spinal cord. There are limited reports of NMOSD...

    Authors: Yangchun Li, Man Tang, Lu Yu, Ying He, Lisong Liang, Hao Qu, Wei Si and Xiao Hu
    Citation: BMC Neurology 2023 23:189
  49. Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread pain and associated symptoms. We investigated cerebral activation in FMS patients by functional near-infrared spectroscopy (fNIRS).

    Authors: Nurcan Üçeyler, Julia Zeller, Susanne Kewenig, Sarah Kittel-Schneider, Andreas J. Fallgatter and Claudia Sommer
    Citation: BMC Neurology 2015 15:210

Annual Journal Metrics

  • 2022 Citation Impact
    2.6 - 2-year Impact Factor
    2.9 - 5-year Impact Factor
    1.092 - SNIP (Source Normalized Impact per Paper)
    0.771 - SJR (SCImago Journal Rank)

    2023 Speed
    26 days submission to first editorial decision for all manuscripts (Median)
    154 days submission to accept (Median)

    2023 Usage 
    3,186,031 downloads
    2,601 Altmetric mentions 

Sign up for article alerts and news from this journal